Moderna antibody preliminary temporary workers neglect to select enough minorities, inciting lull Kumar Jeetendra | October 6, 2020 Private contractors hired by Moderna Inc to recruit volunteers for its coronavirus vaccine trial failed to enrol enough Black, Latino and Native American participants to ascertain how well the vaccine works in such populations, company executives and vaccine researchers told Reuters. To compensate for the shortfall, Moderna slowed registration of its late-stage trial and educated …
DRL gets DCGI s gesture to direct COVID-19 immunization stage 2/3 human preliminaries Kumar Jeetendra | October 17, 2020 Dr.Reddys Laboratories Ltd. and Russian Direct Investment Fund, Russias autonomous wealth fund, on Saturday announced they have received approval from the Drug Control General of India to conduct an adaptive phase 2/3 human clinical trial for Sputnik V vaccine in India. The city-based drug maker said in a press release that this will be a …
GSK, Sanofi to make 200 million doses accessible for COVID-19 antibody union Kumar Jeetendra | October 28, 2020 French drugmaker Sanofi SA and Britain’s GlaxoSmithKline plan to create 200 million doses of the COVID-19 vaccine candidate accessible to the vaccine allocation program co-led by GAVI and the World Health Organization. The companies said on October 28 they have signed a statement of intent with vaccine alliance GAVI, which is coordinating the global plan …
India sees early vaccine dispatch as AstraZeneca conveyances run late Kumar Jeetendra | November 6, 2020 A vaccine is seen as the world’s best bet for taming a virus that has infected more than 48 million people, led to over 1.2 million deaths, roiled markets and disrupted countless lives because it was first identified in China in December. Australia is beefing up its potential arsenal against the pandemic to 135 million …
Researchers translate why COVID-19 spares in kids Kumar Jeetendra | November 14, 2020 Researchers have found an integral aspect that might explain why the book coronavirus predominantly affects adults and older individuals while seeming to spare younger kids, an advance that may lead to the development of new treatment strategies for COVID-19. According to the researchers, including those from the Vanderbilt University Medical Center (VUMC) in the united …
Pfizer Seeks Emergency Use approvals For Its COVID-19 Vaccine In India Kumar Jeetendra | December 6, 2020 Pfizer India has submitted an application on December 4 to the DCGI hunting emergency use authorization (EUA) for its COVID-19 vaccine in India. The firm has filed the EUA program in Form CT-18 for grant of permission to import and market Pfizer-BioNTech’s COVID-19 mRNA vaccine BNT162b2 in the nation,” the source said, citing the program. …
Emergency use SEC approval for Bharat Biotech Covaxin Kumar Jeetendra | January 2, 2021 The SEC has recommended Covaxin for emergency use authorisation (EUA), reported news agency ANI quoting government sources. The recommendation, together with rollout modalities, will be taken up from the Drug Controller General of India (DCGI) to get a final decision on the issue. The Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO) …
Panthera began dosing volunteers in AstraZeneca’s phase III of its long-acting antibody combination AZD7442 for the prevention of COVID-19 at its sites in Preston, North Manchester and North London Kumar Jeetendra | January 5, 2021 Panthera’s clinical trial sites in Preston, North Manchester and North London began dosing volunteers in the Phase III PROVENT trial which will evaluate AstraZeneca’s long-acting antibody combination, AZD7442, for the potential prevention of COVID-19. The double-blind, placebo-controlled trial will include adult volunteers who have no history of COVID-19 and have an increased risk of infection, …
WHO says close to Pfizer deal that would give poorer nations access Kumar Jeetendra | January 19, 2021 The World Health Organization is in advanced negotiations with Pfizer to include the company’s COVID-19 shot in the body’s vaccine-sharing strategy, which would speed vaccine deliveries to poorer countries, a senior WHO official said on Monday. The COVAX scheme — headed by the WHO and GAVI vaccine alliance — is due to begin rolling out …
South Africa halts AstraZeneca immunization after shots fall flat against new variation Kumar Jeetendra | February 8, 2021 South Africa halted Monday’s planned rollout of AstraZeneca’s COVID-19 vaccinations after data showed that it gave minimal protection against moderate infection from one variant, stoking fears of a much longer cat-and-mouse battle with the pathogen. The coronavirus has killed 2.3 million people and turned regular life upside down for countless but new versions have raised …
Industry looks for interest in COVID-19 immunization program: CII Kumar Jeetendra | February 18, 2021 Indian industry has sought involvement from the continuing COVID-19 vaccination programme in order to help the government reach its identified target priority groups quicker, which is crucial for getting the workforce back to work and the economy back on track, the Confederation of Indian Industry (CII) said on Thursday. To action the successful roll out …
Sputnik V vaccine authorized in India Kumar Jeetendra | April 13, 2021 Moscow, April 13, 2021 – The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund) announces that Drug Controller General of India (DCGI) has approved the use of the Russian Sputnik V vaccine against coronavirus in the country. India has become the 60th country to approve Sputnik V. Sputnik V is one of only three …
